Amsurg Corp (AMSG) : Msf Capital scooped up 18,083 additional shares in Amsurg Corp during the most recent quarter end , the firm said in a disclosure report filed with the SEC on May 13, 2016. The investment management firm now holds a total of 21,176 shares of Amsurg Corp which is valued at $1.6 Million.Amsurg Corp makes up approximately 5.42% of Msf Capital’s portfolio.
Other Hedge Funds, Including , Mazama Capital Management Inc reduced its stake in AMSG by selling 8,504 shares or 62.6% in the most recent quarter. The Hedge Fund company now holds 5,080 shares of AMSG which is valued at $380,898. Amsurg Corp makes up approx 0.08% of Mazama Capital Management Inc’s portfolio. Lazard Asset Management sold out all of its stake in AMSG during the most recent quarter. The investment firm sold 6,380 shares of AMSG which is valued $478,372.Amalgamated Bank boosted its stake in AMSG in the latest quarter, The investment management firm added 545 additional shares and now holds a total of 6,007 shares of Amsurg Corp which is valued at $450,405. Amsurg Corp makes up approx 0.04% of Amalgamated Bank’s portfolio.Nationwide Fund Advisors boosted its stake in AMSG in the latest quarter, The investment management firm added 12,018 additional shares and now holds a total of 158,340 shares of Amsurg Corp which is valued at $12.1 Million. Amsurg Corp makes up approx 0.05% of Nationwide Fund Advisors’s portfolio.
Amsurg Corp opened for trading at $75.07 and hit $75.67 on the upside on Wednesday, eventually ending the session at $74.89, with a gain of 0.60% or 0.45 points. The heightened volatility saw the trading volume jump to 4,28,448 shares. Company has a market cap of $4,104 M.
On the company’s financial health, Amsurg Corp reported $0.82 EPS for the quarter, beating the analyst consensus estimate by $ 0.04 according to the earnings call on May 3, 2016. Analyst had a consensus of $0.78. The company had revenue of $724.70 million for the quarter, compared to analysts expectations of $702.21 million. The company’s revenue was up 27.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.62 EPS.
Many Wall Street Analysts have commented on Amsurg Corp. Company shares were Reiterated by Mizuho on May 4, 2016 to “Buy”, Firm has raised the Price Target to $ 90 from a previous price target of $84 .Mizuho Initiated Amsurg Corp on Apr 1, 2016 to “Buy”, Price Target of the shares are set at $84.
AmSurg Corp. is the owner and operator of ambulatory surgery centers (ASCs) in the United States. The Company is also a provider of outsourced physician services in the areas of anesthesiology childrens services emergency medicine and radiology. The Company operates in two segments: ambulatory surgery services and outsourced physician services. The ambulatory services segment which acquires develops and operates ambulatory surgery centers in partnership with physicians. The physician services segment which provides outsourced physician services in multiple specialties to hospitals ambulatory surgery centers and other healthcare facilities primarily in the areas of anesthesiology childrens services emergency medicine and radiology. It operated approximately 246 ASCs in over 34 states and the District of Columbia in partnership with approximately 2000 physicians and provided physician services to over 320 healthcare facilities in 24 states.